Coronavirus Cure?
Off
Andrea Gambotto, antibodies, coronavirus, COVID-19, EBioMedicine, FDA, flu, Louis Falo, MERS-CoV, microneedle array, pandemic, Pitt, PittCoVacc, Pittsburgh Coronavirus Vaccine, SARS, SARS-CoV, SARS-CoV-2, skin, spike protein, The Lancet, U.S. Food and Drug Administration, Univeristy of Pittsburgh, University of Pittsburgh School of Medicine, UPMC, vaccine
Pitt’s COVID-19 Vaccine Successful in Trials In two previous viral outbreaks, spanning almost 20 years, researchers at the University of Pittsburgh worked to develop vaccines. That experience served them well in the race to develop a preventative treatment for the Read More
